GT Biopharma (OXIA.F) Q2 2026 Earnings

18MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-1.9
-1.29
-0.68
-0.07

Details

Expected EPS
-0.06833840000000001
Actual EPS
N/A
Surprise EPS
0.07
Surprise Percent
+100%

Description

GT Biopharma (OXIA.F) will report earnings of for Q2 2026 on May 18, 2026.

0 Comments

Share your thoughts